foy 251 has been researched along with aldosterone in 1 studies
| Studies (foy 251) | Trials (foy 251) | Recent Studies (post-2010) (foy 251) | Studies (aldosterone) | Trials (aldosterone) | Recent Studies (post-2010) (aldosterone) |
|---|---|---|---|---|---|
| 9 | 0 | 2 | 25,333 | 1,517 | 4,169 |
| Protein | Taxonomy | foy 251 (IC50) | aldosterone (IC50) |
|---|---|---|---|
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0048 | |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 0.043 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, M; Kakizoe, Y; Kitamura, K; Ko, T; Maekawa, A; Miyoshi, T; Shiraishi, N; Tomita, K; Wakida, N | 1 |
1 other study(ies) available for foy 251 and aldosterone
| Article | Year |
|---|---|
Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.
Topics: Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Cells, Cultured; Esters; Gabexate; Guanidines; Hypertension; Kidney; Mice; Rats; Rats, Inbred Dahl; RNA, Small Interfering; Serine Endopeptidases; Serine Proteinase Inhibitors | 2009 |